Meet the Board

Kathy is an experienced public company board member and Audit Committee Chair with over 30 years of leading and advising boards of public and high-growth companies on finance, accounting, compensation, mergers & acquisitions, initial public offerings, governance, strategy and operations. Kathy currently serves as a Non-executive Director and Audit Committee Chair for Tecsys (TO: TCS), a leading supply chain and complex distribution management system provider; Non-Executive Director, Audit Committee and Compensation Committee member for IOU Financial (TSXV:IOU), a fintech small business lender; Non-Executive Director, Audit Committee and Governance Committee member for Kaleyra (NYSE:KLR), an omnichannel business communications platform; and Audit Committee Chair for True Commerce, a private equity backed leader in EDI and multi-enterprise supply chain eCommerce and business networks.Prior to her retirement, Kathy was CFO of Nitro Software, Inc. (ASX: NTO), a high growth SaaS-based workflow productivity company, where she contributed to 200% recurring revenue CAGR and 95% client retention. Through her CFO role and at the board level, she led the ASX IPO for this $40M business. Previously, Kathy led dual roles as CFO and COO of nCourt LLC, a high-growth SaaS-based software and payment service provider with $4B+ in processed funds, overseeing all operational and financial functions.Kathy earned a MS in the Study of Law, magna cum laude from Fordham University and a BS in Accounting, cum laude from Alfred University.

• Chair of Audit & Risk Committee.
• Former CFO of Nitro Software (ASX:NTO); former CFO & COO of nCourt LLC overseeing all operational and financial functions
• Non-executive director of Tecsys, IOU Financial, Kaleyra, and TrueCommerce
• M.S. in the Study of Law, magna cum laude from Fordham University; B.S. in Accounting from Alfred University

Dr. Akerman is an optometrist and an experienced executive in the vision care industry, with 41 years of leadership in eye care, new product development, clinical and regulatory affairs, academic and professional affairs, business development and licensing, and executive management.  He earned his Doctor of Optometry degree at the Illinois College of Optometry and his MBA at the University of Texas at Tyler.

• Chair of Science & Technology Committee
• Optometrist and experienced vision care industry executive primarily with Alcon, formerly CIBA Vision, most recently as VP and Global Head of Professional Affairs and Business Development
• Chief Medical Editor of “Review of Myopia Management”
• Doctorate of Optometry from Illinois College of Optometry and MBA at University of Texas at Tyler

Dr. Rubenstein, Clinical Professor of Neurology and Pediatrics at NYU Medical Center, is an  experienced public company board director, a successful entrepreneur, and a respected physician/scientist.  He served for 29 years on the board of The Cooper Companies, Inc. (NYSE: COO) as either Chairman or Vice-Chairman and  Lead Director for all but two of those years. The Cooper Companies, Inc. is the parent company of CooperVision, one of the largest contact lens companies in the world.Dr. Rubenstein is known for his pioneering work on research and treatment of neurofibromatosis (“NF”), a rare genetic disorder, and has long-standing   commercial interests in genomics, ocular conditions and treatments, and  medical devices.Dr. Rubenstein achieved success early in his career by founding, growing, and selling a national medical imaging company. He then founded and served as CEO of NexGenix Pharmaceuticals, which developed drugs for cancer and genetic disorders. He is the founder of the Children’s Tumor Foundation and currently advises several  privately-held medical technology companies  as well as the Tufts University Graduate School of Biomedical Sciences.Dr. Rubenstein earned a BA from Cornell University,  his medical degree from  Tufts University School of Medicine, and did his residency training at the Columbia-Presbyterian NY Neurologic Institute.

• Chair of Nomination and Remuneration Committee
• Former Chair of Cooper Companies (NYSE:COO), parent company of CooperVision
• Founder and CEO of multiple companies; currently head of Scientific Advisory Board of two vision care companies and member of the advisory board for the Tufts University Graduate School of Biomedical Sciences
• B.A. from Cornell and M.D. from Tufts University School of Medicine

Andrew has over 20 years of experience as an investor and leader in the global money management industry.  Currently with Thorney Investment Group, Andrew possesses deep experience and relationships in investment management, capital markets, and investment banking, and has held impactful roles at Talpion Fund Management, Fred Alger Management and Mark Asset Management.  Andrew is a graduate of Brooklyn College with a Bachelor of Science degree in Business, Management and Finance.

• Investor and leader in the global money management industry
• Investment Manager with Thorney Investment Group Australia Pty Ltd, one of the Company’s largest security holders
• Former: Senior Portfolio Manager with Talpion Fund Management; Partner and Portfolio Manager of Mark Asset Management; SVP and Portfolio Manager of Fred Alger Management
• B.S. from Brooklyn College

Juan Carlos (JC) has over 30 years of leadership experience in the vision care industry.  As the former President of CooperVision Specialty EyeCare, he oversaw global operations including one of the largest orthokeratology providers in China. JC also previously held senior roles in CIBA Vision (now Alcon) and Bausch + Lomb.  JC has an Optometry degree from the Superior School of Medicine of the National Polytechnic Institute in Mexico City.

• Current CEO of VTI
• Over 30 years of leadership experience in the vision care industry.
• Former President of CooperVision Specialty EyeCare, overseeing global operations including one of the largest orthokeratology providers in China.
• Previously held senior roles in CIBA Vision (now Alcon) and Bausch + Lomb.
• Optometry degree from the Superior School of Medicine of the National Polytechnic Institute in Mexico City.